down arrow

Adline Chem Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE276T01018
  • NSEID:
  • BSEID: 524604
INR
9.40
-0.36 (-3.69%)
BSENSE

Apr 11, 11:29 AM

BSE+NSE Vol: 200

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Lupin
Dr Reddy's Labs
Sun Pharma.Inds.
Torrent Pharma
Mankind Pharma
Adline Chem Lab
Fabino Enter
Ganga Pharma.
Triochem Product
Why is Adline Chem Lab Ltd ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
  • Poor long term growth as Net Sales has grown by an annual rate of -100.00% and Operating profit at -0.61% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
Flat results in Sep 24
  • PBT LESS OI(Q) Lowest at Rs -0.10 cr.
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-0.61%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
1.00
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
82.07%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
6
Industry P/E
24
Price to Book Value
-3.33
EV to EBIT
-7.15
EV to EBITDA
-7.15
EV to Capital Employed
-7.15
EV to Sales
NA
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
PBT LESS OI(Q)

Lowest at Rs -0.10 cr.

Loading Valuation Snapshot...
Here's what is not working for Adline Chem Lab
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.10 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."